Evaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline Glargine

NCT00518427 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Type 2

Interventions

DRUG: Insulin Glargine

Sponsor

Sanofi